Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Van den Eynde group

Professor Benoit Van den Eynde

 

The Van den Eynde group studies immune responses to cancer, with the long-term goal of harnessing the immune system to fight cancer.

We aim to develop next-generation cancer vaccines that induce a robust cytotoxic CD8+ T cell response and to combine the vaccines with checkpoint inhibitors and/or other approaches for cancer treatment.

 

Find out more about research in the Van den Eynde lab.

 

Our team

Latest Van den Eynde group news

Selected publications